Geneos Wealth Management’s Comscore SCOR Stock Holding History

Geneos Wealth Management’s Portfolio SCOR Stock Details SCOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300	Closed	-$23K	–	2863
2021 Q3	$23K	Hold	300	–	–	﹤0.01%	1858
2021 Q2	$29K	Hold	300	–	–	﹤0.01%	1736
2021 Q1	$22K	Hold	300	–	–	﹤0.01%	2038
2020 Q4	$21K	Buy	+300	New	+$13.3K	﹤0.01%	1883

Other funds holding SCOR

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Geneos Wealth Management's SCOR Position: Q4 2021 in Review

Geneos Wealth Management sold out of Comscore (SCOR) in Q4 2021, closing a stake of 300 shares — an estimated $23K sold.

Geneos Wealth Management first reported a position in SCOR in Q4 2020 and held it in 4 quarters. The position peaked at $29K in Q2 2021. 99 funds tracked by Wall St. Rank hold SCOR as of Q4 2021.

Geneos Wealth Management reported no remaining Comscore position as of Q4 2021 after selling out during the quarter.
Geneos Wealth Management sold 300 Comscore shares in Q4 2021, an estimated $23K.
Geneos Wealth Management first reported a position in Comscore in Q4 2020 and held it in 4 quarters.
Geneos Wealth Management's Comscore position peaked at $29K in Q2 2021.
99 funds tracked by Wall St. Rank held Comscore as of Q4 2021.

Based on Geneos Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.